KATHE REITMAN: Open Payments
NPI 1972688406 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 11 payments from 5 companies in 2025. Trend: 2023 $1,284 · 2024 $962 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Corium, LLC | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: CAPLYTA, Azstarys, REXULTI, AUSTEDO XR, COBENFY.
Industry payments across AZ — which companies pay providers there.
